Advertisement Journal says opioids viable COX-2s alternative - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Journal says opioids viable COX-2s alternative

Opioids could be used as an alternative to the controversial class of COX-2 arthritis and pain relief medications, according to an article published in the new Journal of Opioid Management.

Opioids are often used in combination with other analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs) in particular. With the discovery of an increased risk of cardiovascular events affecting popular COX-2 inhibitors such as Merck & Co’s Vioxx and Pfizer’s Celebrex and Bextra, opioids could provide an important and viable substitute for pain management.

The Journal of Opioid Management is a new bimonthly publication led by editor-in-chief Dr Robert Enck, which is designed to provide doctors with important information regarding the correct use and management of opioids.

“There is a wide chasm between physician and nurse understanding of opioid use and pain management in general,” said Dr Enck, who also holds the same position with the American Journal of Hospice and Palliative Medicine. “Hopefully, the Journal of Opioid Management can close this gap.”